ABSTRACT
Then soon after that the WHO got involved. There was a study that was sponsored by the WHO soon after that to be carried out at a few of the WHO centres in Central and West Africa, and coordinated from the WHO regional office in Brazzaville. HIV/AIDS was more prevalent in areas like the DRC and Congo and so they used some of their collaborating laboratories there. Our role was only to supply the medication. And I remembered when the meeting was being held in Geneva to review the data. One of the investigators in the meeting said, “I went through this, these are my results”, and then we asked, “But how did you administer the product?” So he said, “As per protocol”, but people in the audience said, “No, he didn’t.” Then one of the other investigators said, “No, the principle investigator did not advise the patients to allow the product to disintegrate and be absorbed in the mouth.” On the contrary, the patients were advised to swallow the product with plenty of water! Because the moment you allow this product to disintegrate in the mouth, you must allow some time for the drug to be absorbed to trigger the signals because we believe then and now that this signalling effect was necessary to effect change. Yes, that is why you require such a little amount of product to create that signal which will then create the subsequent cascade of events, including about 30 different types of events that take place shortly after that.
